# RareAgents：针对罕见疾病诊断与治疗的自主多学科团队

发布时间：2024年12月16日

`Agent` `罕见疾病`

> RareAgents: Autonomous Multi-disciplinary Team for Rare Disease Diagnosis and Treatment

# 摘要

> 罕见疾病虽个体发病率低，但因其种类繁多，在全球范围内总计影响约 3 亿人。症状复杂，相关经验丰富的专科医生又短缺，这让罕见疾病的诊断和治疗比常见疾病更棘手。近来，由大型语言模型（LLMs）驱动的代理在多个领域都有显著提升。在医学领域，一些代理方法在医学考试的问答任务中表现优于直接提示。然而，当下的代理框架难以适应现实临床场景，尤其是涉及罕见疾病复杂需求的场景。为应对这些挑战，我们推出了 RareAgents，这是首个专为罕见疾病复杂临床情境打造的基于 LLM 的多学科代理团队。RareAgents 整合了先进的规划能力、记忆机制以及医疗工具的运用，以 Llama-3.1-8B/70B 为基础模型。实验结果显示，在罕见疾病的鉴别诊断和药物推荐方面，RareAgents 超越了最先进的特定领域模型、GPT-4o 以及现有的代理框架。此外，我们还贡献了一个新的数据集——MIMIC-IV-Ext-Rare，它源自 MIMIC-IV，以助力该领域的进一步发展。

> Rare diseases, despite their low individual incidence, collectively impact around 300 million people worldwide due to the huge number of diseases. The complexity of symptoms and the shortage of specialized doctors with relevant experience make diagnosing and treating rare diseases more challenging than common diseases. Recently, agents powered by large language models (LLMs) have demonstrated notable improvements across various domains. In the medical field, some agent methods have outperformed direct prompts in question-answering tasks from medical exams. However, current agent frameworks lack adaptation for real-world clinical scenarios, especially those involving the intricate demands of rare diseases. To address these challenges, we present RareAgents, the first multi-disciplinary team of LLM-based agents tailored to the complex clinical context of rare diseases. RareAgents integrates advanced planning capabilities, memory mechanisms, and medical tools utilization, leveraging Llama-3.1-8B/70B as the base model. Experimental results show that RareAgents surpasses state-of-the-art domain-specific models, GPT-4o, and existing agent frameworks in both differential diagnosis and medication recommendation for rare diseases. Furthermore, we contribute a novel dataset, MIMIC-IV-Ext-Rare, derived from MIMIC-IV, to support further advancements in this field.

[Arxiv](https://arxiv.org/abs/2412.12475)